Excerpt
Clinical practice guidelines are condition- or disease-specific recommendations for the appropriate health care management of patients. Because guidelines can differ between different organizations, the National Academies Roundtable on Genomics and Precision Health and National Cancer Policy Forum hosted a public workshop in October 2024 to explore how clinical guidelines can impact the adoption and coverage of genomic testing in routine medical care.
Copyright 2025 by the National Academy of Sciences. All rights reserved.
PubMed Disclaimer
Grants and funding
SPONSORS This workshop was partially supported by contracts between the National Academies of Sciences and 23andMe, Inc; American Academy of Nursing; American Association for Cancer Research; American Cancer Society; American College of Medical Genetics and Genomics; American College of Radiology; American Medical Association; American Society of Clinical Oncology; American Society of Human Genetics; Association for Molecular Pathology; Association of American Cancer Institutes; Association of Community Cancer Centers; Biogen; Blue Cross Blue Shield Association; Cancer Center at Illinois; Centers for Disease Control and Prevention (Contract No. 75D30121D11240, Task Order No.75D30124F00042); College of American Pathologists; Flatiron Health; Geisinger Health; Genome Medical, Inc.; Health Resources and Services Administration (Contract No. HHSH250201500001I, Task Order No. 75R60220F34021); Illumina, Inc; The Jackson Laboratory (JAX); Kaiser Foundation Health Plan, Inc.; Merck; Myriad Genetics; National Comprehensive Cancer Network; National Institutes of Health (Contract No. HHSN263201800029I, Task Order No. 75N98023F00019 and 75N98023F00022; Purchase Order No. 75N92024P00357), including All of Us Research Program, National Cancer Institute, National Human Genome Research Institute, National Institute of Mental Health, and National Institute on Aging; National Society of Genetic Counselors; Novartis Oncology; Oncology Nursing Society; Partners In Health; Patient Advocate Foundation; Pfizer Inc.; the University of California, San Francisco; and the University of Vermont Health Network Medical Group.
